Proteomics International Laboratories (ASX:PIQ) received a AU$500,000 grant from the Western Australian government to accelerate the commercialization of its blood test for the early diagnosis of endometriosis, according to a Thursday Australian bourse filing.
The funding was provided by the Western Australian government's Future Health Research and Innovation Fund. It will contribute to commercialization activities, including regulatory engagement, marketing, and partnership development.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.